• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Med Sci . Expression of ACE2, TMPRSS2, and SARS-CoV-2 nucleocapsid protein in gastrointestinal tissues from COVID-19 patients and association

tetano

Editor, Senior Moderator
Am J Med Sci


. 2023 Sep 1;S0002-9629(23)01324-1.
doi: 10.1016/j.amjms.2023.08.014. Online ahead of print. Expression of ACE2, TMPRSS2, and SARS-CoV-2 nucleocapsid protein in gastrointestinal tissues from COVID-19 patients and association with gastrointestinal symptoms

Lu Lin[SUP] 1 [/SUP], Famin Zeng[SUP] 2 [/SUP], Lei Mai[SUP] 1 [/SUP], Minzhao Gao[SUP] 1 [/SUP], Zhaoxiong Fang[SUP] 1 [/SUP], Baihe Wu[SUP] 1 [/SUP], Siwen Huang[SUP] 1 [/SUP], Honggang Shi[SUP] 1 [/SUP], Jianzhong He[SUP] 2 [/SUP], Ye Liu[SUP] 2 [/SUP], Xiaofeng Li[SUP] 1 [/SUP], Zhanyu Li[SUP] 3 [/SUP], Yanzhi Han[SUP] 4 [/SUP], Zhixiang Yan[SUP] 5 [/SUP]



Affiliations
Abstract

Background: Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect the gastrointestinal (GI) tract in coronavirus disease 2019 (COVID-19) patients, the mechanism of GI tract injury is largely unknown. We aimed to study the potential factors that cause COVID-19 GI symptoms.
Methods: We investigated the expression and co-localization of angiotensin converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), SARS-CoV-2 nucleocapsid protein (NP), and the severity of inflammation in GI tissues from COVID-19 patients (n=19) by immunofluorescence and histopathologic staining, and then studied their associations with GI symptoms.
Results: Infected stomach tissues showed significantly higher ACE2 expression than uninfected ones, while infected duodenum tissues showed significantly higher TMPRSS2 expression than uninfected ones. The expression of TMPRSS2 exhibited a moderate correlation with viral NP across different GI tissues, while no significant association was observed between ACE2 and viral NP. Some GI symptoms such as diarrhea and nausea, were related to the expression level of ACE2, TMPRSS2 or the severity of inflammation. Furthermore, age and elevated aspartate transaminase were major risk factors for disease progression.
Conclusions: ACE2 and TMPRSS2 were essential proteins in the SARS-CoV-2 infection of GI tract, while TMPRSS2 rather than ACE2 may play a more important role. GI symptoms may derive from the host receptor expression level and pro-inflammatory response in COVID-19 patients after viral infection of GI tissues, and further exacerbate the disease. So targeting TMPRSS2 and inflammation may represent an effective strategy for treating COVID-19 patients with GI symptoms.

Keywords: SARS-CoV-2; angiotensin converting enzyme 2; gastrointestinal symptoms; nucleocapsid protein; transmembrane serine protease 2.

 
Back
Top Bottom